Skip to main content

FTC v. Endo Pharms. Inc.

FTC v. Endo Pharms. Inc.

Ruling
Action by the FTC was excluded from the automatic stay pursuant to the regulatory powersexception but ultimately dismissed for failure. (D.C. Cir.)
Issue(s)
Automatic Stay; Exceptions; Governmental Unit's Enforcement of Police or Regulatory

ABI Membership is required to access the full summary of FTC v. Endo Pharms. Inc. Please sign in if you are already an ABI member, or otherwise you may Become an ABI Member

:
Judge or Jurisdiction information not available
Commercial opinion summary, case decided on August 25, 2023 , LexisNexis #1023-055